GO FIRST OPERATES ESSENTIAL MEDICAL CARGO CHARTER FLIGHT TO TASHKENT
GO FIRST OPERATES ESSENTIAL MEDICAL CARGO CHARTER FLIGHT TO TASHKENT
Hyderabad, July 8, 2021: GO FIRST (formerly known as GoAir) has transported a shipment of essential medical supplies to Tashkent from Delhi.
Aimed at expanding dedicated cargo services in the CIS region, GO FIRST is committed to delivering critical logistics during the pandemic between India and CIS nations.
GO FIRST is focused on improving cargo operations between India and Uzbekistan, as India is the primary exporter of essential pharmaceutical supplies to the country. The charter operations will further enhance and streamline the supply chain for both the pharmaceutical sector and CIS region.
Speaking on the initiative, Mr. Kaushik Khona, Chief Executive Officer, GO FIRST said, “GO FIRST is eyeing expansion in the CIS region including Uzbekistan and this dedicated cargo charter is a step in that direction. These flights will further increase our network in the region and will definitively support the supply chain movement. We are exploring newer avenues in future to enhance and streamline cargo charter experience across our entire network . With GO FIRST’s competitive advantages, companies will greatly benefit from our excellent value added services”.
GO FIRST has been steadfast in its effort to support the nation’s fight against the unprecedented Covid crisis. Recently, the airline ferried oxygen concentrators to Delhi and Patna.
About GO FIRST:
Founded as GoAir, GO FIRST, which was recently rebranded from GO AIR, is the aviation foray of the Wadia Group, which is one of the oldest conglomerates in India that comprises brands including 150-year-old Bombay Burmah, 140-year-old Bombay Dyeing, 102-year-old Britannia Limited., 67-year-old National Peroxide Limited, a [nine-year-old WadiaRealty Private Limited]
Disclaimer: Go Airlines (India) Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares (the “Equity Shares”) and has filed a draft red herring prospectus (the “DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in and the respective websites of the Global Coordinators and Book Running Lead Managers at www.icicisecurities.com; www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm; www.morganstanley.com, respectively.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the DRHP, including the section titled “Risk Factors”. Potential investors should not rely on the DRHP for any investment decision. These materials are not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia). These materials are not an offer of securities for sale into the United States, Canada or Japan. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.
